Literature DB >> 23714309

Immune thrombocytopenia.

Gaurav Kistangari1, Keith R McCrae.   

Abstract

Immune thrombocytopenia (ITP) is a common hematologic disorder characterized by isolated thrombocytopenia. ITP presents as a primary or a secondary form. ITP may affect individuals of all ages, with peaks during childhood and in the elderly, in whom the age-specific incidence of ITP is greatest. Bleeding is the most common clinical manifestation of ITP. The pathogenesis of ITP is complex, involving alterations in humoral and cellular immunity. Corticosteroids remain the most common first line therapy for ITP. This article summarizes the classification and diagnosis of primary and secondary ITP, as well as the pathogenesis and options for treatment.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23714309      PMCID: PMC3672858          DOI: 10.1016/j.hoc.2013.03.001

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  123 in total

1.  A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia.

Authors:  Donald M Arnold; Nancy M Heddle; Julie Carruthers; Deborah J Cook; Mark A Crowther; Ralph M Meyer; Yang Liu; Richard J Cook; Anne McLeod; Janet A MacEachern; Joy Mangel; David Anderson; Linda Vickars; Alan Tinmouth; Andre C Schuh; John G Kelton
Journal:  Blood       Date:  2012-01-05       Impact factor: 22.113

Review 2.  New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome.

Authors:  David T Teachey
Journal:  Curr Opin Pediatr       Date:  2012-02       Impact factor: 2.856

3.  Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group.

Authors:  Thomas Kühne; Willi Berchtold; Lisa A Michaels; Runhui Wu; Hugo Donato; Bibiana Espina; Hannah Tamary; Francesco Rodeghiero; Meera Chitlur; Johannes Rischewski; Paul Imbach
Journal:  Haematologica       Date:  2011-08-31       Impact factor: 9.941

4.  Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic purpura. Physiologic, serologic and isotopic studies.

Authors:  N R Shulman; V J Marder; R S Weinrach
Journal:  Ann N Y Acad Sci       Date:  1965-06-30       Impact factor: 5.691

Review 5.  Childhood immune thrombocytopenia: a changing therapeutic landscape.

Authors:  Vicky R Breakey; Victor S Blanchette
Journal:  Semin Thromb Hemost       Date:  2011-12-20       Impact factor: 4.180

6.  Platelet survival and platelet production in idiopathic thrombocytopenic purpura (ITP).

Authors:  I Branehög; J Kutti; A Weinfeld
Journal:  Br J Haematol       Date:  1974-05       Impact factor: 6.998

7.  T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura.

Authors:  Bob Olsson; Per-Ola Andersson; Margareta Jernås; Stefan Jacobsson; Björn Carlsson; Lena M S Carlsson; Hans Wadenvik
Journal:  Nat Med       Date:  2003-08-24       Impact factor: 53.440

8.  Antibodies against platelet glycoproteins and antiphospholipid antibodies in autoimmune thrombocytopenia.

Authors:  E Lipp; A von Felten; H Sax; D Müller; P Berchtold
Journal:  Eur J Haematol       Date:  1998-05       Impact factor: 2.997

Review 9.  Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production.

Authors:  Diane Nugent; Robert McMillan; Janet L Nichol; Sherrill J Slichter
Journal:  Br J Haematol       Date:  2009-05-14       Impact factor: 6.998

10.  Activity and safety profile of low-dose rituximab for the treatment of autoimmune cytopenias in adults.

Authors:  Drew Provan; Tom Butler; Maria Laura Evangelista; Sergio Amadori; Adrian C Newland; Roberto Stasi
Journal:  Haematologica       Date:  2007-12       Impact factor: 9.941

View more
  36 in total

1.  High frequency of autonomous T-cell proliferation compatible with T-cell large granular lymphocytic leukemia in patients with cytopenia of unknown etiology.

Authors:  Ozlen Bektas; Aysegul Uner; Seda Muruvvet Aydin; Eylem Eliacik; Burak Uz; Ayse Işık; Ibrahim Celalettin Haznedaroğlu; Hakan Goker; Nilgun Sayinalp; Salih Aksu; Halûk Demiroglu; Osman Ilhami Ozcebe; Yahya Buyukasik
Journal:  Int J Hematol       Date:  2015-05-26       Impact factor: 2.490

2.  MicroRNA-125-5p targeted CXCL13: a potential biomarker associated with immune thrombocytopenia.

Authors:  Jian-Qin Li; Shao-Yan Hu; Zhao-Yue Wang; Jing Lin; Su Jian; Yong-Chao Dong; Xiao-Fang Wu; Dai Lan; Li-Juan Cao
Journal:  Am J Transl Res       Date:  2015-04-15       Impact factor: 4.060

3.  Interferon-β therapy and risk of thrombocytopenia in multiple sclerosis patients.

Authors:  Tatiana Koudriavtseva; Domenico Plantone; Rosaria Renna; Chiara Mandoj; Diana Giannarelli; Caterina Mainero
Journal:  Neurol Sci       Date:  2015-07-26       Impact factor: 3.307

4.  Secondary Immune Thrombocytopenic Purpura Due to Primary Epstein- Barr Virus Infection.

Authors:  Heba Yusuf; Aretha Kou; Claire Zelinskas; Girma Ayele; Johnathan Frunzi; Rediet Tefera Atalay; Miriam B Michael
Journal:  Cureus       Date:  2022-06-20

5.  Autoimmune cytopenias and thrombotic thrombocytopenic purpura.

Authors:  Charlotte K Brierley; Sue Pavord
Journal:  Clin Med (Lond)       Date:  2018-08       Impact factor: 2.659

6.  Qian Five Rhinoceros Gindeng (QFRG) protects against development of immune thrombocytopenia via miR-181a inhibition of TLR-4 expression.

Authors:  Yu-Zhou He; Ru-Feng Lu; Chen Zhu; Jun-Yi Hua
Journal:  Int J Clin Exp Med       Date:  2015-05-15

7.  Biliverdin Reductase B Dynamics Are Coupled to Coenzyme Binding.

Authors:  Natasia Paukovich; Mengjun Xue; James R Elder; Jasmina S Redzic; Ashley Blue; Hamish Pike; Brian G Miller; Todd M Pitts; David D Pollock; Kirk Hansen; Angelo D'Alessandro; Elan Zohar Eisenmesser
Journal:  J Mol Biol       Date:  2018-06-20       Impact factor: 5.469

8.  Efficacy and Safety of Avatrombopag in Patients with Chronic Immune Thrombocytopenia: A Systematic Literature Review and Network Meta-Analysis.

Authors:  Keith R McCrae; Wojciech Jurczak; Piotr Wojciechowski; Koo Wilson; Jameel Nazir; Iwona Pustułka; Anna Tytuła; Beata Smela; Michał Pochopien; Michael Vredenburg
Journal:  Adv Ther       Date:  2021-05-01       Impact factor: 4.070

9.  Immune thrombocytopenia associated with Hashimoto thyroiditis in a pediatric patient: A case report.

Authors:  Zhiqing Tian; Hu Gao; Dongqiong Xiao; Xihong Li
Journal:  Medicine (Baltimore)       Date:  2021-06-04       Impact factor: 1.817

Review 10.  A Review of miR-326 and Female Related Diseases.

Authors:  Li-Na Lin; Qing-Mei Zhang; Ying-Ying Ge; Bin Luo; Xiao-Xun Xie
Journal:  Acta Histochem Cytochem       Date:  2021-04-22       Impact factor: 1.938

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.